Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia De Feo

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancerBryony Alderman, David Hui, Sandip Mukhopadhyay, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2023
Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depressionGiulia De Feo, Amy A Case, Gregory B Crawford, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 5, 2023
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse eventsJosephine To, Mellar Davis, Andrea Sbrana, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2018
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technologyJean Bousquet, Peter W Hellings, Ioana Agache, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancerBryony Alderman, David Hui, Sandip Mukhopadhyay, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2023
Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depressionGiulia De Feo, Amy A Case, Gregory B Crawford, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 5, 2023
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse eventsJosephine To, Mellar Davis, Andrea Sbrana, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
Clinical and Molecular Allergy : CMA|May 12, 2020
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental DermatologyEustachio Nettis, Caterina Foti, Marina Ambrifi, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2018
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technologyJean Bousquet, Peter W Hellings, Ioana Agache, et al.
Pageof 3